Aged Care Access & AI: A new report argues nurses in aged care lose time to paperwork because clinical guidance is hard to find “in the moment,” and points to generative AI that answers staff questions using approved internal sources to free up more bedside care. Women’s Health Funding & Reimbursement: The Milken Institute flags coverage and reimbursement as a major barrier for women’s health startups, warning that companies often plan products without mapping payment pathways early. Cancer Care Regulatory Update: The FDA’s priority review for subcutaneous amivantamab plus hyaluronidase in recurrent/metastatic head and neck squamous cell carcinoma highlights a dual EGFR/MET approach and how eligibility and response rates may shape post–checkpoint and chemo options. Vaccines in Action: Afghanistan’s Nangarhar polio campaign targets nearly 1 million children, using a mix of injectable and oral doses across districts. Biotech IPO Watch: Vogenx’s $81M IPO brings a metabolic drug candidate for post-bariatric hypoglycemia into public markets as it seeks a first-in-class path for a condition with no FDA-approved therapies. Blood Supply Crisis: The American Red Cross declares a national type O blood supply crisis, warning hospitals may need to postpone elective surgeries. Workforce Pressure: A separate piece notes healthcare organizations are still wrestling with staffing shortages that affect access, staff well-being, and patient outcomes. Antibiotic Resistance Case: A clinical case describes daptomycin-resistant VREfm after transplant-related infection, underscoring rising treatment challenges in high-risk patients.